285 related articles for article (PubMed ID: 23395171)
41. Lysosomal Ca
Erkhembaatar M; Gu DR; Lee SH; Yang YM; Park S; Muallem S; Shin DM; Kim MS
J Bone Miner Res; 2017 Feb; 32(2):385-396. PubMed ID: 27589205
[TBL] [Abstract][Full Text] [Related]
42. Asiaticoside, a component of Centella asiatica attenuates RANKL-induced osteoclastogenesis via NFATc1 and NF-κB signaling pathways.
He L; Hong G; Zhou L; Zhang J; Fang J; He W; Tickner J; Han X; Zhao L; Xu J
J Cell Physiol; 2019 Apr; 234(4):4267-4276. PubMed ID: 30146787
[TBL] [Abstract][Full Text] [Related]
43. Oleanolic acid acetate inhibits osteoclast differentiation by downregulating PLCγ2-Ca(2+)-NFATc1 signaling, and suppresses bone loss in mice.
Kim JY; Cheon YH; Oh HM; Rho MC; Erkhembaatar M; Kim MS; Lee CH; Kim JJ; Choi MK; Yoon KH; Lee MS; Oh J
Bone; 2014 Mar; 60():104-11. PubMed ID: 24361669
[TBL] [Abstract][Full Text] [Related]
44. Sophorae Flos extract inhibits RANKL-induced osteoclast differentiation by suppressing the NF-κB/NFATc1 pathway in mouse bone marrow cells.
Kim JM; Lee JH; Lee GS; Noh EM; Song HK; Gu DR; Kim SC; Lee SH; Kwon KB; Lee YR
BMC Complement Altern Med; 2017 Mar; 17(1):164. PubMed ID: 28335757
[TBL] [Abstract][Full Text] [Related]
45. Inhibition of osteoclast differentiation and bone resorption by sauchinone.
Han KY; Yang D; Chang EJ; Lee Y; Huang H; Sung SH; Lee ZH; Kim YC; Kim HH
Biochem Pharmacol; 2007 Sep; 74(6):911-23. PubMed ID: 17662251
[TBL] [Abstract][Full Text] [Related]
46. Inhibition of receptor activator of nuclear factor-κB ligand (RANKL)-induced osteoclast formation by pyrroloquinoline quinine (PQQ).
Odkhuu E; Koide N; Haque A; Tsolmongyn B; Naiki Y; Hashimoto S; Komatsu T; Yoshida T; Yokochi T
Immunol Lett; 2012 Feb; 142(1-2):34-40. PubMed ID: 22193059
[TBL] [Abstract][Full Text] [Related]
47. Protective Effects of Fermented Oyster Extract against RANKL-Induced Osteoclastogenesis through Scavenging ROS Generation in RAW 264.7 Cells.
Jeong JW; Choi SH; Han MH; Kim GY; Park C; Hong SH; Lee BJ; Park EK; Kim SO; Leem SH; Jeon YJ; Choi YH
Int J Mol Sci; 2019 Mar; 20(6):. PubMed ID: 30901917
[TBL] [Abstract][Full Text] [Related]
48. Docosahexaenoic acid signaling attenuates the proliferation and differentiation of bone marrow-derived osteoclast precursors and promotes apoptosis in mature osteoclasts.
Kim HJ; Ohk B; Yoon HJ; Kang WY; Seong SJ; Kim SY; Yoon YR
Cell Signal; 2017 Jan; 29():226-232. PubMed ID: 27836739
[TBL] [Abstract][Full Text] [Related]
49. α-Linolenic Acid Inhibits Receptor Activator of NF-κB Ligand Induced (RANKL-Induced) Osteoclastogenesis and Prevents Inflammatory Bone Loss via Downregulation of Nuclear Factor-KappaB-Inducible Nitric Oxide Synthases (NF-κB-iNOS) Signaling Pathways.
Song J; Jing Z; Hu W; Yu J; Cui X
Med Sci Monit; 2017 Oct; 23():5056-5069. PubMed ID: 29061958
[TBL] [Abstract][Full Text] [Related]
50. The fungal metabolite (+)-terrein abrogates osteoclast differentiation via suppression of the RANKL signaling pathway through NFATc1.
Nakagawa S; Omori K; Nakayama M; Mandai H; Yamamoto S; Kobayashi H; Sako H; Sakaida K; Yoshimura H; Ishii S; Ibaragi S; Hirai K; Yamashiro K; Yamamoto T; Suga S; Takashiba S
Int Immunopharmacol; 2020 Jun; 83():106429. PubMed ID: 32222639
[TBL] [Abstract][Full Text] [Related]
51. Kalkitoxin Reduces Osteoclast Formation and Resorption and Protects against Inflammatory Bone Loss.
Li L; Yang M; Shrestha SK; Kim H; Gerwick WH; Soh Y
Int J Mol Sci; 2021 Feb; 22(5):. PubMed ID: 33669069
[TBL] [Abstract][Full Text] [Related]
52. Endoplasmic Reticulum-Bound Transcription Factor CREBH Stimulates RANKL-Induced Osteoclastogenesis.
Kim JH; Kim K; Kim I; Seong S; Nam KI; Kim KK; Kim N
J Immunol; 2018 Mar; 200(5):1661-1670. PubMed ID: 29378912
[TBL] [Abstract][Full Text] [Related]
53. Dual Oxidase Maturation Factor 1 Positively Regulates RANKL-Induced Osteoclastogenesis via Activating Reactive Oxygen Species and TRAF6-Mediated Signaling.
Cheon YH; Lee CH; Jeong DH; Kwak SC; Kim S; Lee MS; Kim JY
Int J Mol Sci; 2020 Sep; 21(17):. PubMed ID: 32899248
[TBL] [Abstract][Full Text] [Related]
54. The polymethoxy flavonoid sudachitin suppresses inflammatory bone destruction by directly inhibiting osteoclastogenesis due to reduced ROS production and MAPK activation in osteoclast precursors.
Ohyama Y; Ito J; Kitano VJ; Shimada J; Hakeda Y
PLoS One; 2018; 13(1):e0191192. PubMed ID: 29342179
[TBL] [Abstract][Full Text] [Related]
55. CTRP3 acts as a negative regulator of osteoclastogenesis through AMPK-c-Fos-NFATc1 signaling in vitro and RANKL-induced calvarial bone destruction in vivo.
Kim JY; Min JY; Baek JM; Ahn SJ; Jun HY; Yoon KH; Choi MK; Lee MS; Oh J
Bone; 2015 Oct; 79():242-51. PubMed ID: 26103094
[TBL] [Abstract][Full Text] [Related]
56. Cot kinase promotes Ca2+ oscillation/calcineurin-independent osteoclastogenesis by stabilizing NFATc1 protein.
Kuroda Y; Hisatsune C; Mizutani A; Ogawa N; Matsuo K; Mikoshiba K
Mol Cell Biol; 2012 Jul; 32(14):2954-63. PubMed ID: 22615493
[TBL] [Abstract][Full Text] [Related]
57. Molecular basis of requirement of receptor activator of nuclear factor κB signaling for interleukin 1-mediated osteoclastogenesis.
Jules J; Zhang P; Ashley JW; Wei S; Shi Z; Liu J; Michalek SM; Feng X
J Biol Chem; 2012 May; 287(19):15728-38. PubMed ID: 22416138
[TBL] [Abstract][Full Text] [Related]
58. DOK3 Modulates Bone Remodeling by Negatively Regulating Osteoclastogenesis and Positively Regulating Osteoblastogenesis.
Cai X; Xing J; Long CL; Peng Q; Humphrey MB
J Bone Miner Res; 2017 Nov; 32(11):2207-2218. PubMed ID: 28650106
[TBL] [Abstract][Full Text] [Related]
59. Comparison of the alendronate and irradiation with a light-emitting diode (LED) on murine osteoclastogenesis.
Sohn HM; Ko Y; Park M; Kim B; Park JE; Kim D; Moon YL; Lim W
Lasers Med Sci; 2017 Jan; 32(1):189-200. PubMed ID: 27807651
[TBL] [Abstract][Full Text] [Related]
60. Ca
Liu W; Le CC; Wang D; Ran D; Wang Y; Zhao H; Gu J; Zou H; Yuan Y; Bian J; Liu Z
Toxicology; 2020 Aug; 441():152520. PubMed ID: 32522522
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
